Plasma concentration of pyridostigmine during the antagonism of neuromuscular block.

British journal of anaesthesia 1983 Vol.55(1) p. 27-31

Williams NE, Calvey TN, Chan K

Abstract

The plasma concentrations of pyridostigmine were measured in eight patients during the antagonism of non-depolarizing neuromuscular blockade. After the injection i.v. of pyridostigmine bromide 14.6 mg/70 kg, the concentration of the drug rapidly decreased between 2 and 7 min, and then declined more slowly. After 2 h, significant amounts of pyridostigmine were still present in the plasma of all subjects. In the eight patients studied, the initial half-life was 1.0 +/- 0.3 min and the terminal half-life was 46.4 +/- 6.5 min (mean +/- SEM). Total body clearance of pyridostigmine was 8.7 +/- 1.5 ml min-1 kg-1, and the total apparent volume of distribution was 536 +/- 80 ml kg-1. Possible explanations for the differences between these results and previous studies are considered.

추출된 의학 개체 (NER)

유형영어 표현한국어 / 풀이UMLS CUI출처등장
해부 Plasma scispacy 1
해부 neuromuscular scispacy 1
합병증 non-depolarizing neuromuscular scispacy 1
약물 pyridostigmine C0034261
pyridostigmine
scispacy 1
약물 pyridostigmine bromide C0034262
pyridostigmine bromide
scispacy 1
약물 mg/70 scispacy 1
질환 neuromuscular block C0234119
Neuromuscular inhibition
scispacy 1
기타 patients scispacy 1

MeSH Terms

Adult; Anesthesia, General; Atropine; Female; Half-Life; Humans; Kinetics; Male; Metabolic Clearance Rate; Middle Aged; Pyridostigmine Bromide; Surgery, Plastic; Tubocurarine